Clinical trial
Doxorubicin With or Without Ifosfamide and Pegfilgrastim in Treating Patients…
NCT00061984 · European Organisation for Research and Treatment of Cancer - EORTC, Other · Completed
Key facts
| NCT number | NCT00061984 |
|---|---|
| Title | Doxorubicin With or Without Ifosfamide and Pegfilgrastim in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma |
| Official title | Randomised Trial Of Single Agent Doxorubicin Versus Doxorubicin Plus Ifosfamide In The First Line Treatment Of Advanced Or Metastatic Soft Tissue Sarcoma |
| Lead sponsor | European Organisation for Research and Treatment of Cancer - EORTC, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Sarcoma |
| Intervention type | Biological, Drug, Procedure |
| Interventions | pegfilgrastim, doxorubicin hydrochloride, ifosfamide, multimodality therapy |
| Enrollment | 455 |
| Start date | Apr 1, 2003 |
| Primary completion | May 1, 2010 |
| Completion | Jul 1, 2012 |
| First posted | Jun 6, 2003 |
| Last update posted | Oct 27, 2014 |
| Countries | Austria, Belgium, Canada, Denmark, France, Germany, Netherlands, Slovakia, Spain, Switzerland, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: